Focus on… Selection of chemical probes for target validation: part one
In part one of a three-part editorial, Albert Antolin, Paul Workman and Bissan Al-Lazikani (The Institute of Cancer Research, London, UK) discuss the limitations of target validation and how to assess chemical probes (estimated read time: 7 minutes).
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.